NEWS  I  MEDIA COVERAGE  I  VIDEOS

RNI In The News

James Fisher and Kate Snow

Deep brain stimulation may ease opioid addiction when other treatments fail

NBC Nightly News

Doctors at West Virginia University’s Rockefeller Neuroscience Institute are testing the experimental procedure on patients for whom other treatments didn’t work.

Addiction treatment had failed. Could brain surgery save him?

The Washington Post

Experimental surgery has kept Gerod Buckhalter sober for more than 600 days. His success shows what may be possible.

Brain surgery may combat opioid addiction.

Good Morning America

Deep brain stimulation, or DBS, via pacemaker technology may help those battling the addiction, which kills 128 Americans every day.

Drug addict kicks lifelong opioid habit after surgery rewires his brain

The Times

After 15 years as a drug addict and having tried and failed with every treatment he could find, Gerod Buckhalter was offered a radical alternative

WVU Rockefeller Neuroscience Institute first in region, among first in U.S. to offer latest deep brain stimulation technology for patients with Parkinson’s

WVU Medicine News

The West Virginia University Rockefeller Neuroscience Institute (RNI) today (June 14) announced the first procedure in West Virginia and Pennsylvania, and among the first in the U.S., to use new deep brain stimulation (DBS) technology that has the potential to improve the treatment of Parkinson’s disease, tremor, dystonia, and other movement disorders

In Appalachia and the Mississippi Delta, Millions Face Long Drives to Stroke Care

US News

Despite medical advancements in stroke care, routing patients from rural parts of Appalachia and the Delta to the appropriate facility is an intricate jigsaw puzzle.

Magnetic stimulation dampens brain response to drug cues in addiction

WVU Today

As part of an ongoing commitment to battle opioid addiction, the WVU Rockefeller Neuroscience Institute marked a major milestone, enrolling the first patient in a randomized clinical trial that will test the effectiveness of an injectable non-opioid, non-steroid micropellet to treat sciatica.

First in the World Clinical Trial of Non-Opioid Micropellet for Chronic Pain

PBS NewsHour

The RNI team demonstrated that repetitive use of transcranial magnetic stimulation (TMS) is successful for in reducing craving for opioids.

New technology from WVU Rockefeller Neuroscience Institute aims to predict coronavirus symptoms

NBC Clarksburg

Researchers at the WVU Rockefeller Neuroscience Institute (RNI) have developed new tools, including the forecasting of temperature and a “health index,” to warn users of the onset of coronavirus-related symptoms and signs of infection in real time

WVU Medicine Department of Behavioral Medicine and Psychiatry is named Center of Excellence, receives grant

WVU Medicine News

The Department of Behavioral Medicine and Psychiatry at the WVU Rockefeller Neuroscience Institute has been named a Center of Excellence in Addiction and was awarded a four-year, $2.9 million grant by the West Virginia Department of Health and Human Resources (WV DHHR). It is the only addiction program in the state to be recognized as a Center of Excellence by the WV DHHR.

W.Va.-Based Study Aims To Predict Coronavirus Exposure Early

WV PBS

That was when researchers at nearby West Virginia University wondered if there was a way to use the physiological experiences of health care workers to help determine if they had contracted the coronavirus, possibly before they themselves knew it.

Breastfeeding may give babies a language boost by influencing brain growth

WVU Today

Breastfeeding may “rewire” babies’ brains in ways that help them acquire language and eventually learn to read, according to a new study from the West Virginia University Rockefeller Neuroscience Institute.

Smart Rings from WVU could detect COVID-19 before symptoms show

NBC Pittsburgh

In the fight against COVID-19, smart rings are being studied as a way to predict if someone will test positive before they show any signs.

WVU Rockefeller Neuroscience Institute publishes study on new treatment for Alzheimer’s patients

NBC Clarksburg

The West Virginia University Rockefeller Neuroscience Institute has announced a new study published in partnership with Weill Cornell Medical Center that demonstrates the successful opening of the blood-brain barrier in the hippocampus and entorhinal cortex using focused ultrasound to treat six patients with early onset Alzheimer’s disease.

Coronavirus in West Virginia: WV doctors develop ‘digital PPE’ to keep those on the frontlines safe

CBS Charleston

A team of West Virginia university doctors and neuroscientists have developed a new early detection device to help aid in the battle against the coronavirus.

WVU is using smart rings, apps and algorithms to identify COVID-19 infections before symptoms occur

Pittsburgh Post-Gazette

For three years the West Virginia University Rockefeller Neuroscience Center has equipped 30,000 people with smart rings and smartphone apps to determine, before any signs of illness, whether they had influenza.

James Fisher Gerald Buckhalter

Deep brain stimulation may ease opioid addiction when other treatments fail

NBC Today

Doctors at West Virginia University’s Rockefeller Neuroscience Institute are testing the experimental procedure on addicts for whom other treatments didn’t work.

Mars? The next frontier is much closer

The Hill

What is it about a frontier? Whether it is a continent, the Moon or, today, the planet Mars, a frontier is a powerful motivator that speaks to a drive inside all of us to go further and higher.

Meet Judi Polak, Alzheimer’s patient and star of a clinical trial showing promising results

PBS NewsHour

The WVU Rockefeller Neuroscience Institute was the first in the world to use focused ultrasound to treat a patient with Alzheimer’s disease.

WVU addresses addiction crisis with novel ultrasound treatment

WVU Today

On the heels of the country’s deadliest year for drug overdoses, the West Virginia University Rockefeller Neuroscience Institute launched a first-in-the-world clinical trial to investigate the use of focused ultrasound technology to treat those with opioid use disorder.

WVU Medicine neurosurgeon performs first awake craniotomy at Berkeley Medical Center

WVU Medicine News

Jonathan H. Sherman, M.D., F.A.A.N.S., F.A.C.S, board certified neurosurgeon with the WVU Rockefeller Neuroscience Institute in Martinsburg, recently performed the first awake craniotomy at WVU Medicine Berkeley Medical Center.

New radiology research shows promise for focused ultrasound treatment of Alzheimer’s

WVU Today

Alzheimer’s disease is the nation’s most common form of dementia, accounting for between 60% and 80% of all dementia cases. And it’s on the rise. The Alzheimer’s Association reports that 5.8 million Americans age 65 and older had Alzheimer’s dementia in 2020. By 2050, that number could rise to 13.8 million.

WVU researchers continue studies to decrease stroke morbidity and mortality

WVU Today

A group of West Virginia University researchers will continue a basic and translational study to decrease the morbidity and mortality related to stroke.

West Virginia University study connects pacemaker to the brain to treat opioid addiction

NewsNation Now

A rise in opioid addiction and drug-related deaths is another effect of the coronavirus pandemic across the country, according to the Centers for Disease Control and Prevention. It’s hitting especially hard in West Virginia, and West Virginia University is in the middle of a groundbreaking study aimed at solving the problem.

RNI gives patient hope and a steady hand, to hold those he loves the most

CBS Pittsburgh

WVU Medicine is the first and only health system in West Virginia and the region using MR-guided focused ultrasound to treat Essential Tremor and Parkinson’s Disease.

Gold medalist and Marine Corp. among those benefiting from Human Performance Innovation Lab

ESPN

The RNI’s Human Performance Innovation Center has created a living laboratory that is helping athletes get stronger cognitively, physically, and emotionally, as well as improving recovery with state-of-the-art technology.

Wearable tech can spot coronavirus symptoms before you even realize you’re sick. Here’s how.

The Washington Post

The RNI is applying its Integrated Neuroscience infrastructure to  rapidly deploy an innovative national study to understand the spread of COVID-19, while protecting our health and economy.

New center for neuroscience research brings together faculty, students across WVU

WVU Today

Just as nerve cells don’t work in isolation when we think, speak or move, scientists don’t work alone when they study the nervous system.

Integrating all components of neurosciences under one roof

WVU School of Medicine News

The RNI established a new department, the Department of Neuroradiology. The department’s mission is to advance knowledge of the nervous system through imaging and to use that knowledge for delivering targeting therapies in the head, neck, and spine.

The Pandemic Is Stressing Your Body in New Ways

The New York Times

The RNI established a new department, the Department of Neuroradiology. The department’s mission is to advance knowledge of the nervous system through imaging and to use that knowledge for delivering targeting therapies in the head, neck, and spine.

Berry named Behavioral Medicine and Psychiatry chair

WVU News

James Berry DO, has been named to lead the WVU School of Medicine’s Department of Behavioral Medicine and Psychiatry as the permanent chair, effective May 1.

Predicting when health care workers could get COVID-19

Pittsburgh Buisness Times

One of the major challenges about the COVID-19 virus is that symptoms often don’t appear for several days, even though the individual is already contagious. But a clinical trial led by the West Virginia University Rockefeller Neuroscience Institute using a smart ring and artificial intelligence is hoping to trim the time for health care workers.

GIVING OPPORTUNITIES

This fund allows the Rockefeller Neuroscience Institute to break barriers in research and patient care.

Your generosity provides momentum for the Rockefeller Neuroscience Institute to leverage cutting-edge technologies and strategic alliances to overcome the barriers to resolving some of the most persistent public health challenges, ranging from addiction to Alzheimer’s disease.